ARTICLE | Clinical News
Architect HbA1c regulatory update
July 16, 2012 7:00 AM UTC
Abbott received CE Mark approval for its Architect HbA1c (IA) assay to quantitatively determine the percent of HbA1c in human whole blood. HbA1c levels are used to monitor long-term diabetes control. ...